Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy
Evgenii N. Tcyganov(The Wistar Institute), Emilio Sanseviero(AstraZeneca (United States)), Douglas Marvel(The Wistar Institute), Thomas Beer(The Wistar Institute), Hsin‐Yao Tang(The Wistar Institute), Peter Hembach(The Wistar Institute), David W. Speicher(The Wistar Institute), Qianfei Zhang(AstraZeneca (United States)), Laxminarasimha Donthireddy(The Wistar Institute), Mostafa Ali(AstraZeneca (United States)), Sabina Tsyganova(University of Pennsylvania), В. М. Писарев(Central Research Institute of Epidemiology), Terri M. Laufer(University of Pennsylvania), Dmitriy Ignatov(Max Planck Unit for the Science of Pathogens), Soldano Ferrone(Harvard University), Christiane Meyer(University of Lausanne), Hélène Maby–El Hajjami(University of Lausanne), Daniel E. Speiser(University of Lausanne), Sooner Altiok(Moffitt Cancer Center), Scott Antonia(Duke Medical Center), Xiaowei Xu(University of Pennsylvania), Wei Xu(University of Pennsylvania), Cathy Zheng(University of Pennsylvania), Lynn M. Schuchter(University of Pennsylvania), Ravi K. Amaravadi(University of Pennsylvania), Tara C. Mitchell(University of Pennsylvania), Giorgos C. Karakousis(University of Pennsylvania), Zhe Yuan(The Wistar Institute), Luis J. Montaner(The Wistar Institute), Esteban Celis(Augusta University Health), Dmitry I. Gabrilovich(AstraZeneca (Netherlands))
Cited by 50Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis